I think the complication was involved in the Japanese approval.The FDA approval was to be straight foward according to mention of this in various presentations I have read.What ever the hold up selling at the low $3.00s is short sighted to say the least.
If I was a seller I be looking over my shoulder for Murphys law
Regards,